95470-42-1

Basic information

• Product Name: IFLAB-BB F2108-0155
• Synonyms: IFLAB-BB F2108-0155;2-BROMO-5-METHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER;2-BROMO-5-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER;2-Bromo-5-methyl-4H-imidazole-4-carboxylic acid ethyl ester;ethyl 2-broMo-5-Methyl-1H-iMidazole-4-carboxylate;Ethyl 2-broMo-5-Methyl-4H-iMidazole-4-carboxylate;Ethyl 2-bromo-4-methyl-1H-imidazole-5-carboxylate;1H-Imidazole-5-carboxylic acid,2-bromo-4-methyl-,ethyl ester
• CAS NO: 95470-42-1
• Molecular Formula: C₇H₉BrN₂O₂
• Molecular Weight: 233.07
• Mol File: 95470-42-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 152-153 °C
• Boiling Point: 265.275 °C at 760 mmHg
• Flash Point: 114.235 °C
• Appearance: /
• Density: 1.656 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.81±0.10(Predicted)
• CAS DataBase Reference: IFLAB-BB F2108-0155(CAS DataBase Reference)
• NIST Chemistry Reference: IFLAB-BB F2108-0155(95470-42-1)
• EPA Substance Registry System: IFLAB-BB F2108-0155(95470-42-1)

Safety Data

• Hazardous Substances Data: 95470-42-1(Hazardous Substances Data)

Usage

General Description

IFLAB-BB F2108-0155, also known as 4-(Methylthio)benzaldehyde, is a chemical compound with the molecular formula C8H8OS. It is a colorless to light yellow liquid with a strong, pungent odor, and is commonly used in the production of fragrances and flavorings. IFLAB-BB F2108-0155 is frequently employed as a starting material in the synthesis of various organic compounds and pharmaceutical intermediates. Its unique aromatic and sulfurous characteristics make it a valuable ingredient in the manufacturing of perfumes, soaps, and other scented products. Additionally, 4-(Methylthio)benzaldehyde has been utilized in scientific research as a reagent and in analytical chemistry for its ability to react with various compounds, enabling the identification and quantification of specific chemical substances.

Upstream product

• 51605-32-4 ethyl 4⁽⁵⁾-methylimidazole-5⁽⁴⁾-carboxylate 
• 51605-32-4 Ethyl 5-Methyl-4-imidazolecarboxylate 

Downstream Products

• 139261-79-3 ethyl 2-(N-piperidino)-4(5)-methyl-5(4)-imidazole carboxylate hydrochloride 
• 139261-80-6 ethyl 2-p-chlorophenylamino-4⁽⁵⁾-methyl-5⁽⁴⁾-imidazole carboxylate hydrochloride 
• 113444-43-2 ethyl 2-bromo-1,4-dimethyl-1H-imidazole-5-carboxylate 
• 103968-59-8 ethyl 2-bromo-1,5-dimethyl-1H-Imidazole-4-Carboxylate 
• 1224479-50-8 C₁₉H₂₅N₃O₂ 
• 444325-66-0 C₁₉H₂₆BrN₃O₂ 
• 1224479-82-6 C₁₆H₂₁N₃O₂ 
• 444326-23-2 C₁₈H₂₂BrN₃O₃ 
• 1238538-84-5 C₁₈H₂₂BrN₃O₃ 

Relevant articles and documents

HETEROARYL INHIBITORS OF PAD4

The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.

PYRAZINE DERIVATIVE

Provided is a novel pyrazine derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof which is useful for treating or preventing diseases in which URAT1 is involved, including gout, hyperurice

IMIDAZOLE DERIVATIVE

PROBLEM TO BE SOLVED: To provide a novel pyrazine derivative that is useful as a therapeutic agent or preventive agent for diseases associated with URAT1, such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, diabetes,